<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
  <channel>
    <title>Insulet Corporation — News on 6ix</title>
    <link>https://6ix.com/company/insulet-corporation</link>
    <description>Latest news and press releases for Insulet Corporation on 6ix.</description>
    <language>en-us</language>
    <lastBuildDate>Wed, 01 Apr 2026 04:00:00 GMT</lastBuildDate>
    <generator>6ix RSS</generator>
    <atom:link href="https://6ix.com/rss/company/insulet-corporation" rel="self" type="application/rss+xml" />
    <image>
      <url>https://6ix-events-pro.s3.amazonaws.com/6ixvideo/logos/org-logo6835af3f78dffbe2df10f29f.webp</url>
      <title>Insulet Corporation</title>
      <link>https://6ix.com/company/insulet-corporation</link>
    </image>
    <item>
      <title>Insulet to Announce First Quarter 2026 Financial Results on May 6, 2026</title>
      <link>https://6ix.com/company/insulet-corporation/news/insulet-to-announce-first-quarter-2026-financial-results-on-may-6-2026-1</link>
      <guid isPermaLink="true">https://6ix.com/company/insulet-corporation/news/insulet-to-announce-first-quarter-2026-financial-results-on-may-6-2026-1</guid>
      <pubDate>Wed, 01 Apr 2026 04:00:00 GMT</pubDate>
      <description>ACTON, Mass.--(BUSINESS WIRE)-- Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the global leader in tubeless insulin pump technology with its</description>
    </item>
    <item>
      <title>Insulet Appoints Mike Panos as Chief Commercial Officer</title>
      <link>https://6ix.com/company/insulet-corporation/news/insulet-appoints-mike-panos-as-chief-commercial-officer</link>
      <guid isPermaLink="true">https://6ix.com/company/insulet-corporation/news/insulet-appoints-mike-panos-as-chief-commercial-officer</guid>
      <pubDate>Mon, 30 Mar 2026 04:00:00 GMT</pubDate>
      <description>ACTON, Mass.--(BUSINESS WIRE)-- Insulet Corporation (NASDAQ: PODD) (“Insulet” or the “Company”), the global leader in tubeless insulin pump technology with</description>
    </item>
    <item>
      <title>Insulet Initiates Voluntary Medical Device Correction for Certain Omnipod® 5 Pods in the U.S.</title>
      <link>https://6ix.com/company/insulet-corporation/news/insulet-initiates-voluntary-medical-device-correction-for-certain-omnipodr-5-pods-in-the-us</link>
      <guid isPermaLink="true">https://6ix.com/company/insulet-corporation/news/insulet-initiates-voluntary-medical-device-correction-for-certain-omnipodr-5-pods-in-the-us</guid>
      <pubDate>Thu, 12 Mar 2026 20:05:00 GMT</pubDate>
      <description>ACTON, Mass., March 12, 2026--Insulet Initiates Voluntary Medical Device Correction for Certain Omnipod® 5 Pods in the U.S.</description>
    </item>
    <item>
      <title>Insulet Presents Promising Study Results for Fully Closed-Loop Automated Insulin Delivery System for Adults with Type 2 Diabetes</title>
      <link>https://6ix.com/company/insulet-corporation/news/insulet-presents-promising-study-results-for-fully-closed-loop-automated-insulin-delivery-system-for-adults-with-type-2-diabetes-15</link>
      <guid isPermaLink="true">https://6ix.com/company/insulet-corporation/news/insulet-presents-promising-study-results-for-fully-closed-loop-automated-insulin-delivery-system-for-adults-with-type-2-diabetes-15</guid>
      <pubDate>Wed, 11 Mar 2026 04:00:00 GMT</pubDate>
      <description>Outcomes from EVOLUTION 2 study include 68% time in range with no boluses Diverse multicenter feasibility study highlights the promise of future Omnipod</description>
    </item>
    <item>
      <title>Insulet to Present EVOLUTION 2 Results on Omnipod® Fully Closed-Loop System for Adults with Type 2 Diabetes at International Conference on Advanced Technologies &amp; Treatments for Diabetes (ATTD)</title>
      <link>https://6ix.com/company/insulet-corporation/news/insulet-to-present-evolution-2-results-on-omnipodr-fully-closed-loop-system-for-adults-with-type-2-diabetes-at-international-conference-on-advanced-technologies-and-treatments-for-diabetes-attd</link>
      <guid isPermaLink="true">https://6ix.com/company/insulet-corporation/news/insulet-to-present-evolution-2-results-on-omnipodr-fully-closed-loop-system-for-adults-with-type-2-diabetes-at-international-conference-on-advanced-technologies-and-treatments-for-diabetes-attd</guid>
      <pubDate>Tue, 10 Mar 2026 04:00:00 GMT</pubDate>
      <description>Fully Closed-Loop System Feasibility Study to be presented at Insulet Symposium and in e-Poster during ATTD 2026 Real World Evidence of Settings Optimization</description>
    </item>
    <item>
      <title>Insulet Reports Fourth Quarter and Full Year 2025 Results</title>
      <link>https://6ix.com/company/insulet-corporation/news/insulet-reports-fourth-quarter-and-full-year-2025-results</link>
      <guid isPermaLink="true">https://6ix.com/company/insulet-corporation/news/insulet-reports-fourth-quarter-and-full-year-2025-results</guid>
      <pubDate>Wed, 18 Feb 2026 12:00:00 GMT</pubDate>
      <description>ACTON, Mass., February 18, 2026--Insulet Reports Fourth Quarter and Full Year 2025 Results</description>
    </item>
    <item>
      <title>Insulin Pump Market Insights $2.1B Revenue from Insulet, 500,000+ U.S. Users and 47.8% Adoption in Canada Driven by Government Funding</title>
      <link>https://6ix.com/company/insulet-corporation/news/insulin-pump-market-insights-dollar21b-revenue-from-insulet-500000-us-users-and-478percent-adoption-in-canada-driven-by-government-funding</link>
      <guid isPermaLink="true">https://6ix.com/company/insulet-corporation/news/insulin-pump-market-insights-dollar21b-revenue-from-insulet-500000-us-users-and-478percent-adoption-in-canada-driven-by-government-funding</guid>
      <pubDate>Fri, 06 Feb 2026 13:00:00 GMT</pubDate>
      <description>This report provides an in-depth analysis of the insulin pump market, highlighting key trends in pricing, manufacturing, and sales growth from 2020 to 2035. It is published by a sister firm of Precedence Research, focusing on advancements in healthcare technologies and their impact on diabetes management.Ottawa, Feb. 06, 2026 (GLOBE NEWSWIRE) -- Over the past few years, the insulin pump market has experienced impressive growth, thanks to improvements in diabetes management technology and the ris</description>
    </item>
    <item>
      <title>Insulet Launches Omnipod® 5 and Omnipod Discover™ in the Middle East to Transform Diabetes Care</title>
      <link>https://6ix.com/company/insulet-corporation/news/insulet-launches-omnipod-5-omnipod-120000991</link>
      <guid isPermaLink="true">https://6ix.com/company/insulet-corporation/news/insulet-launches-omnipod-5-omnipod-120000991</guid>
      <pubDate>Thu, 05 Feb 2026 12:00:00 GMT</pubDate>
      <description>ACTON, Mass., February 05, 2026--Insulet Launches Omnipod® 5 and Omnipod Discover™ in the Middle East to Transform Diabetes Care</description>
    </item>
    <item>
      <title>Insulet to Announce Fourth Quarter and Full Year 2025 Financial Results on February 18, 2026</title>
      <link>https://6ix.com/company/insulet-corporation/news/insulet-announce-fourth-quarter-full-110000578</link>
      <guid isPermaLink="true">https://6ix.com/company/insulet-corporation/news/insulet-announce-fourth-quarter-full-110000578</guid>
      <pubDate>Fri, 09 Jan 2026 11:00:00 GMT</pubDate>
      <description>ACTON, Mass., January 09, 2026--Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod® brand of products, today announced it will report financial results for the fourth quarter and full year of 2025 on February 18, 2026, before the opening of the financial markets. In connection with the release, management will host a conference call that day at 8:00 a.m. (Eastern Time).</description>
    </item>
    <item>
      <title>Insulet to Announce Fourth Quarter and Full Year 2025 Financial Results on February 18, 2026 </title>
      <link>https://6ix.com/company/insulet-corporation/news/insulet-announce-fourth-quarter-and-full-year-2025-financial-results-february-18-2026</link>
      <guid isPermaLink="true">https://6ix.com/company/insulet-corporation/news/insulet-announce-fourth-quarter-and-full-year-2025-financial-results-february-18-2026</guid>
      <pubDate>Fri, 09 Jan 2026 05:00:00 GMT</pubDate>
      <description>ACTON, Mass.--(BUSINESS WIRE)-- Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the global leader in tubeless insulin pump technology with its</description>
    </item>
    <item>
      <title>Insulet Redefines Diabetes at CES with &quot;Liveable Technology&quot; — A New Frontier in Human-Centered Connected Health</title>
      <link>https://6ix.com/company/insulet-corporation/news/insulet-redefines-diabetes-ces-liveable-120000584</link>
      <guid isPermaLink="true">https://6ix.com/company/insulet-corporation/news/insulet-redefines-diabetes-ces-liveable-120000584</guid>
      <pubDate>Tue, 06 Jan 2026 12:00:00 GMT</pubDate>
      <description>ACTON, Mass., January 06, 2026--Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the global leader in tubeless insulin pump technology with its...</description>
    </item>
    <item>
      <title>Insulet to Participate in 44th Annual J.P. Morgan Healthcare Conference</title>
      <link>https://6ix.com/company/insulet-corporation/news/insulet-participate-44th-annual-jp-morgan-healthcare-conference-2025-12-16</link>
      <guid isPermaLink="true">https://6ix.com/company/insulet-corporation/news/insulet-participate-44th-annual-jp-morgan-healthcare-conference-2025-12-16</guid>
      <pubDate>Tue, 16 Dec 2025 05:00:00 GMT</pubDate>
      <description>ACTON, Mass.--(BUSINESS WIRE)-- Insulet Corporation (NASDAQ: PODD), the global leader in tubeless insulin pump technology with its Omnipod® brand of</description>
    </item>
    <item>
      <title>Insulet Expands Omnipod® U.S. Recycling Program, Diverting Millions of Pods from Landfills and Creating a More Sustainable Future</title>
      <link>https://6ix.com/company/insulet-corporation/news/insulet-expands-omnipodr-us-recycling-program-diverting-millions-pods-landfills-and</link>
      <guid isPermaLink="true">https://6ix.com/company/insulet-corporation/news/insulet-expands-omnipodr-us-recycling-program-diverting-millions-pods-landfills-and</guid>
      <pubDate>Mon, 15 Dec 2025 05:00:00 GMT</pubDate>
      <description>Expansion follows successful multi-year pilots in Massachusetts and California, and longstanding Pod takeback programs in Europe, Canada, and Australia</description>
    </item>
    <item>
      <title>Insulet Announces FDA 510(k) Clearance of Omnipod® 5 Algorithm Enhancements that Redefine Insulin Delivery and Simplify the Pod Experience</title>
      <link>https://6ix.com/company/insulet-corporation/news/insulet-announces-fda-510k-clearance-omnipodr-5-algorithm-enhancements-redefine</link>
      <guid isPermaLink="true">https://6ix.com/company/insulet-corporation/news/insulet-announces-fda-510k-clearance-omnipodr-5-algorithm-enhancements-redefine</guid>
      <pubDate>Thu, 04 Dec 2025 05:00:00 GMT</pubDate>
      <description>New 100 mg/dL Target Glucose setting offers more customization and tighter glucose management. Enhanced algorithm helps users remain in Automated Mode to</description>
    </item>
    <item>
      <title>Insulet Outlines Long-Term Strategy to Drive Growth and Value Creation at 2025 Investor Day</title>
      <link>https://6ix.com/company/insulet-corporation/news/insulet-outlines-long-term-strategy-drive-growth-and-value-creation-2025-investor-day</link>
      <guid isPermaLink="true">https://6ix.com/company/insulet-corporation/news/insulet-outlines-long-term-strategy-drive-growth-and-value-creation-2025-investor-day</guid>
      <pubDate>Thu, 20 Nov 2025 05:00:00 GMT</pubDate>
      <description>Company announces strong long-range financial outlook for 2025–2028 Introduces next-generation innovation pipeline to transform diabetes care ACTON,</description>
    </item>
    <item>
      <title>Insulet Reports Third Quarter 2025 Results</title>
      <link>https://6ix.com/company/insulet-corporation/news/insulet-reports-third-quarter-2025-results-2025-11-06</link>
      <guid isPermaLink="true">https://6ix.com/company/insulet-corporation/news/insulet-reports-third-quarter-2025-results-2025-11-06</guid>
      <pubDate>Thu, 06 Nov 2025 05:00:00 GMT</pubDate>
      <description>Raises Full Year Revenue and Margin Guidance ACTON, Mass.--(BUSINESS WIRE)-- Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the global leader</description>
    </item>
    <item>
      <title>Insulet Champions Workplace Inclusion for People with Diabetes with New Data and Tools Released for Diabetes Awareness Month</title>
      <link>https://6ix.com/company/insulet-corporation/news/insulet-champions-workplace-inclusion-people-diabetes-new-data-and-tools-released</link>
      <guid isPermaLink="true">https://6ix.com/company/insulet-corporation/news/insulet-champions-workplace-inclusion-people-diabetes-new-data-and-tools-released</guid>
      <pubDate>Thu, 30 Oct 2025 04:00:00 GMT</pubDate>
      <description>Insulet launches campaign inspired by the International Diabetes Federation’s focus on diabetes, well-being, and the workplace “The Day Diabetes Showed Up to</description>
    </item>
    <item>
      <title>Insulet Announces Appointment of Robert L. Huffines to its Board of Directors</title>
      <link>https://6ix.com/company/insulet-corporation/news/insulet-announces-appointment-robert-l-huffines-its-board-directors-2025-10-23</link>
      <guid isPermaLink="true">https://6ix.com/company/insulet-corporation/news/insulet-announces-appointment-robert-l-huffines-its-board-directors-2025-10-23</guid>
      <pubDate>Thu, 23 Oct 2025 04:00:00 GMT</pubDate>
      <description>ACTON, Mass.--(BUSINESS WIRE)-- Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the global leader in tubeless insulin pump technology with its</description>
    </item>
    <item>
      <title>Insulet to Host Investor Day on November 20, 2025</title>
      <link>https://6ix.com/company/insulet-corporation/news/insulet-host-investor-day-november-20-2025-2025-10-10</link>
      <guid isPermaLink="true">https://6ix.com/company/insulet-corporation/news/insulet-host-investor-day-november-20-2025-2025-10-10</guid>
      <pubDate>Fri, 10 Oct 2025 04:00:00 GMT</pubDate>
      <description>ACTON, Mass.--(BUSINESS WIRE)-- Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the global leader in tubeless insulin pump technology with its</description>
    </item>
    <item>
      <title>Insulet and Pantone® Partner to Launch Omnipod® Mango in Vibrant New Palette</title>
      <link>https://6ix.com/company/insulet-corporation/news/insulet-and-pantoner-partner-launch-omnipodr-mango-vibrant-new-palette-2025-09-18</link>
      <guid isPermaLink="true">https://6ix.com/company/insulet-corporation/news/insulet-and-pantoner-partner-launch-omnipodr-mango-vibrant-new-palette-2025-09-18</guid>
      <pubDate>Thu, 18 Sep 2025 04:00:00 GMT</pubDate>
      <description>From Pod to Pantone: Omnipod Mango becomes an iconic color First of its kind collaboration celebrates individualism and a personal journey toward empowerment</description>
    </item>
  </channel>
</rss>